Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF-mutant melanoma

Linked Article: Frauchiger et al. Br J Dermatol 2016; 174: 823–830.

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 174; no. 4; pp. 716 - 717
Main Author Sullivan, R.J.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.04.2016
Subjects
Biomarkers
Biomarkers, Tumor - blood
Humans
Lactate Dehydrogenases
Melanoma - blood
Nerve Growth Factors - blood
Prognosis
S100 Proteins - blood
Online AccessGet full text

Cover

More Information
Summary:Linked Article: Frauchiger et al. Br J Dermatol 2016; 174: 823–830.
Bibliography:istex:59191DFFD61A59D21FEB51650399D088DC40B153
ark:/67375/WNG-C6RZ31MV-0
ArticleID:BJD14503
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.14503